Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patent infringement
Pharma
AbbVie awarded $56M in Botox patent infringement case
A Delaware jury has ruled that Revance infringed three patents on AbbVie's Botox and has awarded a royalty payment of $56 million.
Kevin Dunleavy
Jul 22, 2025 11:22am
Halozyme sues Merck over subcutaneous Keytruda
Apr 24, 2025 2:41pm
AstraZeneca inks $1.35B deal for subcutaneous cancer drugs
Mar 17, 2025 10:55am
Merck, Halozyme dig in for patent fight over injectable Keytruda
Mar 6, 2025 11:18am
Arbutus, Genevant expand COVID patent feud with Moderna
Mar 4, 2025 11:49am
Teva agrees with Axsome to keep generic off market until 2038
Feb 10, 2025 11:28am
